Anterogen Co (XKRX:065660) Ending Cash Position : ₩1,308 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Ending Cash Position?

Anterogen Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩1,308 Mil.

Anterogen Co's quarterly Ending Cash Position declined from Sep. 2023 (₩2,139 Mil) to Dec. 2023 (₩1,389 Mil) and declined from Dec. 2023 (₩1,389 Mil) to Mar. 2024 (₩1,308 Mil).

Anterogen Co's annual Ending Cash Position declined from Dec. 2021 (₩6,968 Mil) to Dec. 2022 (₩3,903 Mil) and declined from Dec. 2022 (₩3,903 Mil) to Dec. 2023 (₩1,389 Mil).

Anterogen Co Ending Cash Position Historical Data

The historical data trend for Anterogen Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Ending Cash Position Chart

Anterogen Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

42,076.32

8,478.87

6,968.33

3,902.72

1,388.68

Anterogen Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															2,493.49	2,931.40	2,138.57	1,388.68	1,308.18

Anterogen Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Anterogen Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3902.716	+	-2514.04
	=	1,389

Anterogen Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1388.675	+	-80.498
	=	1,308

Anterogen Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Anterogen Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Anterogen Co (XKRX:065660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589

Website

http://www.anterogen.com

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co (XKRX:065660) Headlines

No Headlines